Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-small Cell Lung Cancer(NSCLC) · Head and Neck Squamous Cell Carcinoma(HNSCC) · Renal Cell Carcinoma(RCC) · Urothelial Carcinoma · Malignant Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NEXT Oncology, Fairfax, Virginia, United States
Contact: Study coordinator (Alexander Spirra) · alexander.spira@usoncology.com · (703)-783-4508

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of VET3-TGI in Patients With Solid Tumors

Solid Tumor, Adult · Microsatellite Stable Colorectal Cancer · Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Orange, United States

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Hinsdale, United States · New Lenox, United States

A Study of NX-1607 in Adults With Advanced Malignancies

Ovarian Cancer, Epithelial · Gastric Cancer · GastroEsophageal Junction (GEJ) Cancer

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Los Angeles, United States

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Rochester, United States